Skip to Main Content

Paper Details

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS).
J Subst Abuse Treat
13
2021
Author NameAffiliation
Elizabeth Needham WaddellSchool of Public Health and OHSU School of Medicine, Oregon Health & Science University
  • 1 - 1

Datasets

Release 1.2